Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, multicenter, 2-way crossover study in subjects 12 years or older with
perennial allergic rhinitis (PAR) to evaluate patient preference, satisfaction and efficacy
of ciclesonide nasal aerosol versus mometasone aqueous nasal spray. A novel
patient-administered assessment, developed and validated to measure patient satisfaction with
and preference of intranasal corticosteroids (INCS) for the treatment of allergic rhinitis
(AR), is utilized in this study.